CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 120 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,269,913 | -18.7% | 1,024,139 | -40.3% | 0.03% | -24.4% |
| Q2 2023 | $18,777,257 | +10.0% | 1,714,818 | -12.4% | 0.04% | -4.7% |
| Q1 2023 | $17,065,633 | +4822.0% | 1,957,068 | +3439.1% | 0.04% | +4200.0% |
| Q4 2022 | $346,725 | -39.7% | 55,299 | -31.1% | 0.00% | -75.0% |
| Q2 2019 | $575,000 | -18.7% | 80,264 | +50.7% | 0.00% | -20.0% |
| Q1 2019 | $707,000 | -63.2% | 53,247 | -78.2% | 0.01% | -64.3% |
| Q4 2018 | $1,921,000 | +7904.2% | 244,066 | +1837.0% | 0.01% | – |
| Q3 2015 | $24,000 | -38.5% | 12,600 | -12.0% | 0.00% | – |
| Q2 2015 | $39,000 | – | 14,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |